Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8d6602015938cd2436a0379048e006fa |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-439 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D489-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-485 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P23-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-439 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D489-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P23-00 |
filingDate |
2007-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2015-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b3bedc733056f5cf345aed84431ea881 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_963005ff2f23004d764195446cc0b477 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9099718f3daa311afa4d3c0386a8ead3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6aac919cbb4d1a66176255b1221578fd |
publicationDate |
2015-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
ES-2549115-T3 |
titleOfInvention |
Buprenorphine prodrugs administrable transdermally and compositions resistant to excessive consumption thereof |
abstract |
A compound selected from the group consisting of: ** Formula ** and salts thereof. |
priorityDate |
2006-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |